
Releases
Regencell Investors Face June 23 Deadline in Securities Lawsuit
Investors holding Regencell Bioscience shares between October 2024 and October 2025 have until June 23, 2026, to file for lead plaintiff status in a federal class action lawsuit. The litigation targets the company over claims that it misled shareholders regarding its vulnerability to market manipulation and regulatory scrutiny.























